Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1991 Feb 15;144(4):425–431.

Periodic health examination, 1991 update: 1. Screening for cognitive impairment in the elderly. Canadian Task Force on the Periodic Health Examination.

PMCID: PMC1452799  PMID: 1993289

Full text

PDF
425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony J. C., LeResche L., Niaz U., von Korff M. R., Folstein M. F. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982 May;12(2):397–408. doi: 10.1017/s0033291700046730. [DOI] [PubMed] [Google Scholar]
  2. Bazo A. J. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study. J Am Geriatr Soc. 1973 Feb;21(2):63–71. doi: 10.1111/j.1532-5415.1973.tb01220.x. [DOI] [PubMed] [Google Scholar]
  3. Beller S. A., Overall J. E., Swann A. C. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology (Berl) 1985;87(2):147–151. doi: 10.1007/BF00431798. [DOI] [PubMed] [Google Scholar]
  4. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  5. Broe G. A., Akhtar A. J., Andrews G. R., Caird F. I., Gilmore A. J., McLennan W. J. Neurological disorders in the elderly at home. J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):362–366. doi: 10.1136/jnnp.39.4.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bruno G., Mohr E., Gillespie M., Fedio P., Chase T. N. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86. Arch Neurol. 1986 Jul;43(7):659–661. doi: 10.1001/archneur.1986.00520070017009. [DOI] [PubMed] [Google Scholar]
  7. Butler R. N. Age-ism: another form of bigotry. Gerontologist. 1969 Winter;9(4):243–246. doi: 10.1093/geront/9.4_part_1.243. [DOI] [PubMed] [Google Scholar]
  8. Caltagirone C., Gainotti G., Masullo C. Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia. Int J Neurosci. 1982 May;16(3-4):247–249. doi: 10.3109/00207458209147153. [DOI] [PubMed] [Google Scholar]
  9. Campbell A. J., McCosh L. M., Reinken J., Allan B. C. Dementia in old age and the need for services. Age Ageing. 1983 Feb;12(1):11–16. doi: 10.1093/ageing/12.1.11. [DOI] [PubMed] [Google Scholar]
  10. Clarfield A. M. The reversible dementias: do they reverse? Ann Intern Med. 1988 Sep 15;109(6):476–486. doi: 10.7326/0003-4819-109-6-476. [DOI] [PubMed] [Google Scholar]
  11. Cyrus-Lutz C., Gaitz C. M. Psychiatrists' attitudes toward the aged and aging. Gerontologist. 1972 Summer;12(2):163–167. doi: 10.1093/geront/12.2_part_1.163. [DOI] [PubMed] [Google Scholar]
  12. Davis K. L., Mohs R. C., Davis B. M., Horvath T. B., Greenwald B. S., Rosen W. G., Levy M. I., Johns C. A. Oral physostigmine in Alzheimer's disease. Psychopharmacol Bull. 1983;19(3):451–453. [PubMed] [Google Scholar]
  13. DePaulo J. R., Jr, Folstein M. F. Psychiatric disturbances in neurological patients: detection, recognition, and hospital course. Ann Neurol. 1978 Sep;4(3):225–228. doi: 10.1002/ana.410040306. [DOI] [PubMed] [Google Scholar]
  14. Dick J. P., Guiloff R. J., Stewart A., Blackstock J., Bielawska C., Paul E. A., Marsden C. D. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry. 1984 May;47(5):496–499. doi: 10.1136/jnnp.47.5.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Erkinjuntti T., Sulkava R., Wikström J., Autio L. Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc. 1987 May;35(5):412–416. doi: 10.1111/j.1532-5415.1987.tb04662.x. [DOI] [PubMed] [Google Scholar]
  16. Fillenbaum G. G., Heyman A., Wilkinson W. E., Haynes C. S. Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol. 1987 Sep;44(9):924–927. doi: 10.1001/archneur.1987.00520210026014. [DOI] [PubMed] [Google Scholar]
  17. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  18. Folstein M., Anthony J. C., Parhad I., Duffy B., Gruenberg E. M. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985 Apr;33(4):228–235. doi: 10.1111/j.1532-5415.1985.tb07109.x. [DOI] [PubMed] [Google Scholar]
  19. Glosser G., Wexler D., Balmelli M. Physicians' and families' perspectives on the medical management of dementia. J Am Geriatr Soc. 1985 Jun;33(6):383–391. doi: 10.1111/j.1532-5415.1985.tb07147.x. [DOI] [PubMed] [Google Scholar]
  20. Hagnell O., Lanke J., Rorsman B., Ohman R., Ojesjö L. Current trends in the incidence of senile and multi-infarct dementia. A prospective study of a total population followed over 25 years; the Lundby Study. Arch Psychiatr Nervenkr (1970) 1983;233(6):423–438. doi: 10.1007/BF00342783. [DOI] [PubMed] [Google Scholar]
  21. Hagnell O., Lanke J., Rorsman B., Ojesjö L. Does the incidence of age psychosis decrease? A prospective, longitudinal study of a complete population investigated during the 25-year period 1947-1972: the Lundby study. Neuropsychobiology. 1981;7(4):201–211. doi: 10.1159/000117852. [DOI] [PubMed] [Google Scholar]
  22. Hodkinson H. M. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233–238. doi: 10.1093/ageing/1.4.233. [DOI] [PubMed] [Google Scholar]
  23. Hollander E., Davidson M., Mohs R. C., Horvath T. B., Davis B. M., Zemishlany Z., Davis K. L. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Biol Psychiatry. 1987 Sep;22(9):1067–1078. doi: 10.1016/0006-3223(87)90049-7. [DOI] [PubMed] [Google Scholar]
  24. Isaacs B., Akhtar A. J. The set test: a rapid test of mental function in old people. Age Ageing. 1972 Nov;1(4):222–226. doi: 10.1093/ageing/1.4.222. [DOI] [PubMed] [Google Scholar]
  25. Jacobs J. W., Bernhard M. R., Delgado A., Strain J. J. Screening for organic mental syndromes in the medically ill. Ann Intern Med. 1977 Jan;86(1):40–46. doi: 10.7326/0003-4819-86-1-40. [DOI] [PubMed] [Google Scholar]
  26. Jennings W. G. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study. J Am Geriatr Soc. 1972 Aug;20(8):407–412. doi: 10.1111/j.1532-5415.1972.tb01645.x. [DOI] [PubMed] [Google Scholar]
  27. Johnson R. T., Price D. L. Chronic neurological diseases: their societal burdens and potential solutions. J Chronic Dis. 1980;33(3):129–133. doi: 10.1016/0021-9681(80)90012-0. [DOI] [PubMed] [Google Scholar]
  28. Jones E. W. Labeling of the elderly as mentally ill: a community analysis. J Gerontol Nurs. 1982 Apr;8(4):221–224. doi: 10.3928/0098-9134-19820401-09. [DOI] [PubMed] [Google Scholar]
  29. Jorm A. F., Korten A. E., Henderson A. S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987 Nov;76(5):465–479. doi: 10.1111/j.1600-0447.1987.tb02906.x. [DOI] [PubMed] [Google Scholar]
  30. Jotkowitz S. Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease. Ann Neurol. 1983 Dec;14(6):690–691. doi: 10.1002/ana.410140616. [DOI] [PubMed] [Google Scholar]
  31. KAHN R. L., GOLDFARB A. I., POLLACK M., PECK A. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry. 1960 Oct;117:326–328. doi: 10.1176/ajp.117.4.326. [DOI] [PubMed] [Google Scholar]
  32. KAY D. W., BEAMISH P., ROTH M. OLD AGE MENTAL DISORDERS IN NEWCASTLE UPON TYNE. I. A STUDY OF PREVALENCE. Br J Psychiatry. 1964 Mar;110:146–158. doi: 10.1192/bjp.110.465.146. [DOI] [PubMed] [Google Scholar]
  33. Katzman R., Brown T., Fuld P., Peck A., Schechter R., Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983 Jun;140(6):734–739. doi: 10.1176/ajp.140.6.734. [DOI] [PubMed] [Google Scholar]
  34. Kay D. W., Bergmann K., Foster E. M., McKechnie A. A., Roth M. Mental illness and hospital usage in the elderly: a random sample followed up. Compr Psychiatry. 1970 Jan;11(1):26–35. doi: 10.1016/0010-440x(70)90201-4. [DOI] [PubMed] [Google Scholar]
  35. Kay D. W., Henderson A. S., Scott R., Wilson J., Rickwood D., Grayson D. A. Dementia and depression among the elderly living in the Hobart community: the effect of the diagnostic criteria on the prevalence rates. Psychol Med. 1985 Nov;15(4):771–788. doi: 10.1017/s0033291700005006. [DOI] [PubMed] [Google Scholar]
  36. Kaye W. H., Sitaram N., Weingartner H., Ebert M. H., Smallberg S., Gillin J. C. Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment. Biol Psychiatry. 1982 Feb;17(2):275–280. [PubMed] [Google Scholar]
  37. Kiernan R. J., Mueller J., Langston J. W., Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med. 1987 Oct;107(4):481–485. doi: 10.7326/0003-4819-107-4-481. [DOI] [PubMed] [Google Scholar]
  38. Kokmen E., Naessens J. M., Offord K. P. A short test of mental status: description and preliminary results. Mayo Clin Proc. 1987 Apr;62(4):281–288. doi: 10.1016/s0025-6196(12)61905-3. [DOI] [PubMed] [Google Scholar]
  39. Koponen H., Stenbäck U., Mattila E., Soininen H., Reinikainen K., Riekkinen P. J. Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand. 1989 Jun;79(6):579–585. doi: 10.1111/j.1600-0447.1989.tb10306.x. [DOI] [PubMed] [Google Scholar]
  40. Larson E. B., Kukull W. A., Buchner D., Reifler B. V. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987 Aug;107(2):169–173. doi: 10.7326/0003-4819-107-2-169. [DOI] [PubMed] [Google Scholar]
  41. Larson E. B., Reifler B. V., Featherstone H. J., English D. R. Dementia in elderly outpatients: a prospective study. Ann Intern Med. 1984 Mar;100(3):417–423. doi: 10.7326/0003-4819-100-3-417. [DOI] [PubMed] [Google Scholar]
  42. Larson E. B., Reifler B. V., Sumi S. M., Canfield C. G., Chinn N. M. Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J Gerontol. 1985 Sep;40(5):536–543. doi: 10.1093/geronj/40.5.536. [DOI] [PubMed] [Google Scholar]
  43. Lasoski M. C., Thelen M. H. Attitudes of older and middle-aged persons toward mental health intervention. Gerontologist. 1987 Jun;27(3):288–292. doi: 10.1093/geront/27.3.288. [DOI] [PubMed] [Google Scholar]
  44. Lipowski Z. J. Delirium in the elderly patient. N Engl J Med. 1989 Mar 2;320(9):578–582. doi: 10.1056/NEJM198903023200907. [DOI] [PubMed] [Google Scholar]
  45. Little A., Levy R., Chuaqui-Kidd P., Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736–742. doi: 10.1136/jnnp.48.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Magaziner J., Bassett S. S., Hebel J. R. Predicting performance on the Mini-Mental State Examination. Use of age- and education-specific equations. J Am Geriatr Soc. 1987 Nov;35(11):996–1000. doi: 10.1111/j.1532-5415.1987.tb04002.x. [DOI] [PubMed] [Google Scholar]
  47. Marsden C. D., Harrison M. J. Outcome of investigation of patients with presenile dementia. Br Med J. 1972 Apr 29;2(5808):249–252. doi: 10.1136/bmj.2.5808.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  49. Mohs R. C., Davis B. M., Johns C. A., Mathé A. A., Greenwald B. S., Horvath T. B., Davis K. L. Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry. 1985 Jan;142(1):28–33. doi: 10.1176/ajp.142.1.28. [DOI] [PubMed] [Google Scholar]
  50. Molloy D. W., Cape R. D. Acute effects of oral pyridostigmine on memory and cognitive function in SDAT. Neurobiol Aging. 1989 Mar-Apr;10(2):199–204. doi: 10.1016/0197-4580(89)90031-6. [DOI] [PubMed] [Google Scholar]
  51. Molloy D. W., Guyatt G. H., Wilson D. B., Duke R., Rees L., Singer J. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. CMAJ. 1991 Jan 1;144(1):29–34. [PMC free article] [PubMed] [Google Scholar]
  52. Omer H., Foldes J., Toby M., Menczel J. Screening for cognitive deficits in a sample of hospitalized geriatric patients: a re-evaluation of a brief mental status questionnaire. J Am Geriatr Soc. 1983 May;31(5):266–268. doi: 10.1111/j.1532-5415.1983.tb04868.x. [DOI] [PubMed] [Google Scholar]
  53. Pattie A. H., Gilleard C. J. A brief psychogeriatric assessment schedule. Validation against psychiatric diagnosis and discharge from hospital. Br J Psychiatry. 1975 Nov;127:489–493. doi: 10.1192/bjp.127.5.489. [DOI] [PubMed] [Google Scholar]
  54. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975 Oct;23(10):433–441. doi: 10.1111/j.1532-5415.1975.tb00927.x. [DOI] [PubMed] [Google Scholar]
  55. Rao D. B., Norris J. R. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly. Johns Hopkins Med J. 1972 May;130(5):317–324. [PubMed] [Google Scholar]
  56. Ray D. C., Raciti M. A., Ford C. V. Ageism in psychiatrists: associations with gender, certification, and theoretical orientation. Gerontologist. 1985 Oct;25(5):496–500. doi: 10.1093/geront/25.5.496. [DOI] [PubMed] [Google Scholar]
  57. Skurla E., Rogers J. C., Sunderland T. Direct assessment of activities of daily living in Alzheimer's disease. A controlled study. J Am Geriatr Soc. 1988 Feb;36(2):97–103. doi: 10.1111/j.1532-5415.1988.tb01776.x. [DOI] [PubMed] [Google Scholar]
  58. Smith J. S., Kiloh L. G. The investigation of dementia: results in 200 consecutive admissions. Lancet. 1981 Apr 11;1(8224):824–827. doi: 10.1016/s0140-6736(81)92692-1. [DOI] [PubMed] [Google Scholar]
  59. Smyer M. A., Hofland B. F., Jonas E. A. Validity study of the short portable mental status questionnaire for the elderly. J Am Geriatr Soc. 1979 Jun;27(6):263–269. doi: 10.1111/j.1532-5415.1979.tb06128.x. [DOI] [PubMed] [Google Scholar]
  60. Stern Y., Sano M., Mayeux R. Effects of oral physostigmine in Alzheimer's disease. Ann Neurol. 1987 Sep;22(3):306–310. doi: 10.1002/ana.410220305. [DOI] [PubMed] [Google Scholar]
  61. Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med. 1986 Nov 13;315(20):1241–1245. doi: 10.1056/NEJM198611133152001. [DOI] [PubMed] [Google Scholar]
  62. Teng E. L., Chui H. C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987 Aug;48(8):314–318. [PubMed] [Google Scholar]
  63. Thal L. J., Fuld P. A., Masur D. M., Sharpless N. S. Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol. 1983 May;13(5):491–496. doi: 10.1002/ana.410130504. [DOI] [PubMed] [Google Scholar]
  64. Thienhaus O. J., Wheeler B. G., Simon S., Zemlan F. P., Hartford J. T. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia. J Am Geriatr Soc. 1987 Mar;35(3):219–223. doi: 10.1111/j.1532-5415.1987.tb02312.x. [DOI] [PubMed] [Google Scholar]
  65. Warren E. J., Grek A., Conn D., Herrmann N., Icyk E., Kohl J., Silberfeld M. A correlation between cognitive performance and daily functioning in elderly people. J Geriatr Psychiatry Neurol. 1989 Apr-Jun;2(2):96–100. doi: 10.1177/089198878900200209. [DOI] [PubMed] [Google Scholar]
  66. Weissman M. M., Myers J. K., Tischler G. L., Holzer C. E., 3rd, Leaf P. J., Orvaschel H., Brody J. A. Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a U.S. urban community. Acta Psychiatr Scand. 1985 Apr;71(4):366–379. doi: 10.1111/j.1600-0447.1985.tb02536.x. [DOI] [PubMed] [Google Scholar]
  67. Winograd C. H. Mental status tests and the capacity for self-care. J Am Geriatr Soc. 1984 Jan;32(1):49–55. doi: 10.1111/j.1532-5415.1984.tb05150.x. [DOI] [PubMed] [Google Scholar]
  68. Wolber G., Romaniuk M., Eastman E., Robinson C. Validity of the Short Portable Mental Status Questionnaire with elderly psychiatric patients. J Consult Clin Psychol. 1984 Aug;52(4):712–713. doi: 10.1037//0022-006x.52.4.712. [DOI] [PubMed] [Google Scholar]
  69. Yesavage J. A., Hollister L. E., Burian E. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report. J Am Geriatr Soc. 1979 Feb;27(2):80–82. doi: 10.1111/j.1532-5415.1979.tb03345.x. [DOI] [PubMed] [Google Scholar]
  70. van Loveren-Huyben C. M., Engelaar H. F., Hermans M. B., van der Bom J. A., Leering C., Munnichs J. M. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration. J Am Geriatr Soc. 1984 Aug;32(8):584–588. doi: 10.1111/j.1532-5415.1984.tb06137.x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES